Currently Viewing:
Patient-Centered Oncology Care
Dr Thomas Graf: Personalizing Cancer Care Payment Models
April 16, 2018
Dr Stacey McCullough Discusses Teamwork and Collaboration in Oncology
April 13, 2018
Torrie Fields: Collecting and Using Data Can Better Inform a Patient
April 12, 2018
Dr Thomas Graf Discusses the Effect of Novel Therapies on Private Coverage
April 06, 2018
Currently Reading
Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians
April 05, 2018
Dr Thomas Graf: How the Impact of Novel Therapies Varies Among Stakeholders
March 22, 2018
Jason Harris Highlights National Health Council's Recommendations on Real-World Evidence
March 18, 2018
Ian Manners Explains the Impact of Patient Financial Assistance Programs
March 17, 2018
Dr Thomas Graf on the Impact of New Therapies in Oncology
March 12, 2018
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
March 02, 2018
Dr Brenton Fargnoli on Fixing Issues Physicians Have With EHRs
February 18, 2018
Kathleen Lokay: Implementing Value in Clinical Pathways
February 13, 2018
Jason Harris Discusses the Importance of Real-World Evidence
February 11, 2018
Dr Brenton Fargnoli Explains How Quality Measurement Benchmarks Drive Action
February 09, 2018
Kathleen Lokay on Educating Patients on Treatment Options
January 28, 2018
Dr Brenton Fargnoli Discusses the Creation of a Learning Health System
January 25, 2018
Kathleen Lokay on How Data Generation Informs Clinical Pathways
January 16, 2018
Torrie Fields: Data Collection Takes the Guesswork Out of Care
January 01, 2018
Kathleen Lokay: Clinical Pathways Can Prevent Prior Authorization Delays
December 24, 2017

Kathleen Lokay: Incorporating the Latest Research and Supporting Physicians

Committees for Via Oncology meet frequently to update pathway platforms and support the growing needs of physicians, according to Kathleen Lokay.


Committees for Via Oncology meet frequently to update pathway platforms and support the growing needs of physicians, according to Kathleen Lokay.

Transcript

How frequently are your pathways platforms updated to reflect the latest research developments in oncology, especially in the context of using diagnostic tests?

Our medical oncology committees actually meet the most frequently of all. Radiation and surgical oncology don’t meet as often because there’s not as much data changing. But the medical oncology committees meet every quarter. There’s just that much going on in oncology. Then if there is something groundbreaking in between a meeting the committees can always call an ad hoc meeting. So we really want to make sure that we’re addressing new data frequently and that we really keep the pathways up to speed and that new data includes diagnostic tests. So we will be incorporating new biomarkers in virtually every meeting as new data comes out.

Is there anything Via Oncology is thinking about doing next that physicians are looking for?

The thing that we don’t have so much now is precision medicine in the sense of things that are not really standardized care. So if it’s not standardized care, we historical don’t put it in the pathways but we’re increasingly getting our practices asking us to help them with those places where they’re doing genomic sequencing and wanting support for that and wanting to then have their results then be matched with their clinical trials. So it’s stepping outside of what has historically been a more standardized healthcare pathway into something more researched but something that is clearly becoming a bigger and bigger part of practice.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!